Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jul 6;9(19):5325-5331.
doi: 10.12998/wjcc.v9.i19.5325.

Glutamic acid decarboxylase 65-positive autoimmune encephalitis presenting with gelastic seizure, responsive to steroid: A case report

Affiliations
Case Reports

Glutamic acid decarboxylase 65-positive autoimmune encephalitis presenting with gelastic seizure, responsive to steroid: A case report

Camerdy Yue Yang et al. World J Clin Cases. .

Abstract

Background: Anti-glutamic acid decarboxylase (GAD) antibody is known to cause several autoimmune-related situations. The most known relationship is that it may cause type I diabetes. In addition, it was also reported to result in several neurologic syndromes including stiff person syndrome, cerebellar ataxia, and autoimmune encephalitis. Decades ago, isolated epilepsy associated with anti-GAD antibody was first reported. Recently, the association between temporal lobe epilepsy and anti-GAD antibody has been discussed. Currently, with improvements in examination technique, many more autoimmune-related disorders can be diagnosed and treated easier than in the past.

Case summary: A 44-year-old female Asian with a history of end-stage renal disease (without diabetes mellitus) under hemodialysis presented with diffuse abdominal pain. The initial diagnosis was peritonitis complicated with sepsis and paralytic ileus. Her peritonitis was treated and she recovered well, but seizure attack was noticed during hospitalization. The clinical impression was gelastic seizure with the presentation of frequent smiling, head turned to the right side, and eyes staring without focus; the duration was about 5-10 s. Temporal lobe epilepsy was recorded through electroencephalogram, and she was later diagnosed with anti-GAD65 antibody positive autoimmune encephalitis. Her seizure was treated initially with several anticonvulsants but with poor response. However, she showed excellent response to intravenous methylprednisolone pulse therapy. Her consciousness returned to normal, and no more seizures were recorded after 5 d of intravenous methylprednisolone treatment.

Conclusion: In any case presenting with new-onset epilepsy, in addition to performing routine brain imaging to exclude structural lesion and cerebrospinal fluid studies to exclude common etiologies of infection and inflammation, checking the autoimmune profile has to be considered. In the practice of modern medicine, autoimmune-related disorders are relatively treatable and should not be missed.

Keywords: Anti-GAD antibody; Autoimmune encephalitis; Case report; Electroencephalogram; GAD65 antibody; Gelastic seizure.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: All the authors have no conflict of interest related to the manuscript.

Figures

Figure 1
Figure 1
Electroencephalogram. A: A1–A2 montage of electroencephalogram (EEG), frequent generalized paroxysmal sharp waves with maximal amplitude in the left hemisphere were noticed; B: Double banana montage of EEG, focal paroxysmal sharp waves with phase reverse at T3, which are suggestive of focal epileptogenicity in the left temporal region.
Figure 2
Figure 2
Brain magnetic resonance imaging.

Similar articles

References

    1. Jazebi N, Rodrigo S, Gogia B, Shawagfeh A. Anti-glutamic acid decarboxylase (GAD) positive cerebellar Ataxia with transitioning to progressive encephalomyelitis with rigidity and myoclonus (PERM), responsive to immunotherapy: A case report and review of literature. J Neuroimmunol. 2019;332:135–137. - PubMed
    1. Liu Z, Huang Q, Li H, Qiu W, Chen B, Luo J, Yang H, Liu T, Liu S, Xu H, Long Y, Gao C. Glutamic Acid Decarboxylase Antibody in a Patient with Myelitis: A Retrospective Study. Neuroimmunomodulation. 2018;25:68–72. - PubMed
    1. Nemni R, Braghi S, Natali-Sora MG, Lampasona V, Bonifacio E, Comi G, Canal N. Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol. 1994;36:665–667. - PubMed
    1. Joubert B, Rostásy K, Honnorat J. Immune-mediated ataxias. Handb Clin Neurol. 2018;155:313–332. - PubMed
    1. Fileccia E, Rinaldi R, Liguori R, Incensi A, D'Angelo R, Giannoccaro MP, Donadio V. Post-ganglionic autonomic neuropathy associated with anti-glutamic acid decarboxylase antibodies. Clin Auton Res. 2017;27:51–55. - PubMed

Publication types